Eisai has filed to extend the label for its Alzheimer’s disease therapy Leqembi to include a maintenance ... that is specific to the subcutaneous form. In a statement, Eisai and Biogen said ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi ... a subcutaneous form of Kisunla ...

Ange Postecoglou is on the brink after Liverpool smashed Tottenham to knock them out of the Carabao Cup and Aston Villa eased them out of the FA Cup three days later. Which poor sod will be left ...

Subsequent to the closing of the transaction, GENFIT will implement the repurchase of the 2025 OCEANEs at a price of € 32.75 per bond, (the “Repurchase”) and pay the €0.90 consent fee (the ... s 2023 ...

Now participants have been switched from an earlier experimental drug to Leqembi, an IV treatment approved in the U.S., to try to answer the obvious next question. “What we want to determine over the ...

After hours: March 21 at 6:48:26 PM EDT Loading Chart for FORM ...

This advertisement has not loaded yet, but your article continues below. The Prince Edward Island Regulatory and Appeals Commission (IRAC) announced a one-cent change to regular gas prices overnight, ...